The benefits of platelet glycoprotein IIb/IIIa receptor inhibition during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: drug-specific or class effect? Journal of the American College of Cardiology [J Am Coll Cardiol] Journal article